Life Sciences Blog

How Automation Helps Life Sciences Manufacturers Deliver Faster, Safer Therapies

Jim Cahill — Tue, 02 Jun 2026 12:01:39 GMT

Why this matters now The last few decades of biopharmaceutical research have seen an explosion in new therapies, many of which treat illnesses once thought impossible to manage. As innovation continues at an unprecedented pace, life sciences manufacturers are under increasing pressure to deliver new drugs and vaccines faster than ever without compromising safety and […]

The post How Automation Helps Life Sciences Manufacturers Deliver Faster, Safer Therapies appeared first on the Emerson Automation Experts blog.

Visibility for BioPharma Operations: From Data Insights to Better Outcomes

Jim Cahill — Wed, 27 May 2026 18:30:24 GMT

More than 10,000 rare diseases affect over 30 million people in the United States alone, and 95 percent of those diseases have no approved treatment. With more than 1,000 active clinical programs working to change that, the pressure on biopharmaceutical manufacturers to accelerate the pipeline without compromising quality or compliance has never been greater.

The post Visibility for BioPharma Operations: From Data Insights to Better Outcomes appeared first on the Emerson Automation Experts blog.

From Automation Islands to Connected Plants: A Practical Path for Life Sciences Manufacturers

Jim Cahill — Tue, 19 May 2026 12:39:14 GMT

As explored in his recent interview in Pharmaceutical Processing World, Emerson’s Bruce Greenwald—drawing on decades of experience—explains that life sciences manufacturers are moving beyond isolated systems toward connected plants to achieve operational excellence and competitive advantage. A connected plant also streamlines tech transfer across the treatment production pipeline, making connectivity effectively table stakes in today’s […]

The post From Automation Islands to Connected Plants: A Practical Path for Life Sciences Manufacturers appeared first on the Emerson Automation Experts blog.

Hygienic Flow Measurement That Protects Your Process and Your Business

Jim Cahill — Tue, 28 Apr 2026 15:00:10 GMT

In Life Sciences manufacturing, flow measurement is never just about measurement. It’s about protecting product quality, maintaining validation, and ensuring every batch meets exacting regulatory expectations without slowing down operations. That’s exactly why we continue to expand the Micro Motion™ hygienic Coriolis flow meter portfolio. Our goal isn’t to simply offer another hygienic meter. It […]

The post Hygienic Flow Measurement That Protects Your Process and Your Business appeared first on the Emerson Automation Experts blog.

Embedded AI is the Future of Biopharmaceutical Recipe Creation

Jim Cahill — Tue, 28 Apr 2026 12:00:01 GMT

Life sciences may be the ideal industry for the implementation of AI technologies. After all, bringing a treatment all the way through the drug development process is an extremely complicated undertaking, with tremendous amounts of data and a wide array of ever-changing variables to manage. Moreover, every step must be made with an eye on […]

The post Embedded AI is the Future of Biopharmaceutical Recipe Creation appeared first on the Emerson Automation Experts blog.

Turning Flow Data into Operational Advantage: Inside the Micro Motion™︎ Coriolis Transmitter Portfolio

Jim Cahill — Fri, 24 Apr 2026 13:00:49 GMT

Across industries—from chemical and energy to life sciences—operators are being asked to do more with less. Processes must run reliably, systems must integrate smoothly, and regulatory expectations continue to rise. At the same time, traditional approaches to flow measurement verification often introduce downtime, site visits, and uncertainty that teams can’t afford. As product managers for […]

The post Turning Flow Data into Operational Advantage: Inside the Micro Motion™ Coriolis Transmitter Portfolio appeared first on the Emerson Automation Experts blog.

Manufacturing Readiness Is the Next Frontier in Life Sciences AI

Jim Cahill — Wed, 15 Apr 2026 15:20:09 GMT

AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when things still feel calm. Insilico Medicine advanced a novel drug candidate for idiopathic pulmonary fibrosis […]

The post Manufacturing Readiness Is the Next Frontier in Life Sciences AI appeared first on the Emerson Automation Experts blog.

Digital Frameworks Transform Drug Development

Jim Cahill — Tue, 07 Apr 2026 12:29:56 GMT

In the wake of the COVID-19 pandemic and the associated development of a vaccine in record time, the biopharmaceutical industry has seen significant change. Today, we know that faster development is possible, though it is still challenging. That has increased the drive of many organizations to improve speed to market, looking at ways to leverage […]

The post Digital Frameworks Transform Drug Development appeared first on the Emerson Automation Experts blog.

Part 2: Execution Intelligence: Embedding AI Inside Validated Manufacturing

Jim Cahill — Tue, 31 Mar 2026 13:04:30 GMT

In Part 1, we explored why digital strategies that sit above operations break down in regulated life sciences manufacturing. When analytics are disconnected from validated execution, insight loses the context required to support quality, compliance, and release decisions. The next step is not abandoning enterprise data platforms—but evolving how, and where, intelligence is applied. From […]

The post Part 2: Execution Intelligence: Embedding AI Inside Validated Manufacturing appeared first on the Emerson Automation Experts blog.

Part 1: Why AI in Life Sciences Must Be Grounded in Validated Execution

Jim Cahill — Thu, 26 Mar 2026 13:57:05 GMT

The common digital strategy playbook is: unify the data, layer on AI, and drive enterprise-level insight. The strategy sounds compelling in its simplicity. And for some industries and some use cases, it can work. But in regulated life sciences manufacturing, there is a constraint that fundamentally shapes how intelligence must be applied: Manufacturing insight must […]

The post Part 1: Why AI in Life Sciences Must Be Grounded in Validated Execution appeared first on the Emerson Automation Experts blog.

Streamlining Recipe Creation in the Life Sciences Industry

Jim Cahill — Thu, 19 Feb 2026 20:46:11 GMT

A recent news release, Emerson Streamlines Life Sciences Recipe Creation for Faster Time to Market, shares the innovation of the new DeltaV MES Recipe Importer tool.

The post Streamlining Recipe Creation in the Life Sciences Industry appeared first on the Emerson Automation Experts blog.

Delivering Benefits for Emerging Pharma Manufacturers

Jim Cahill — Wed, 11 Feb 2026 18:36:48 GMT

For emerging pharma manufacturers facing urgent imperatives to bring products to market quickly with limited resources and constrained funding, the Digital Batch Record solution, with the Recipe Importer Tool, solves real problems in practical, affordable, and immediately implementable ways.

The post Delivering Benefits for Emerging Pharma Manufacturers appeared first on the Emerson Automation Experts blog.

Batch Disposition Vision and Practical Framework

Jim Cahill — Fri, 06 Feb 2026 14:00:35 GMT

In a recently released BioPhorum paper, BATCH DISPOSITION: A shared vision and practical framework for digitized transformation, Emerson’s Michalle Adkins and Debbie Bouwens joined with other experts in the Life Sciences industry to author this work.

The post Batch Disposition Vision and Practical Framework appeared first on the Emerson Automation Experts blog.

Driving Biotech Manufacturing Performance with Digital Twins

Jim Cahill — Wed, 21 Jan 2026 14:00:55 GMT

A Genetic Engineering & Biotechnology News article, Beyond Process Development: AI Reshaping Use of Digital Twins, highlights the evolving use of digital twin technology in the Life Sciences industry.

The post Driving Biotech Manufacturing Performance with Digital Twins appeared first on the Emerson Automation Experts blog.

Bringing Born-Digital Speed to Every Life Sciences Workflow

Jim Cahill — Tue, 20 Jan 2026 13:56:21 GMT

In the last few years, life sciences innovation has jumped by leaps and bounds. Many of the emerging autologous, patient-specific therapies being released are accomplishing things the general public never thought would be possible. These autologous treatments are highly technology dependent. They require flexible manufacturing and push as close to real-time release as possible. But, […]

The post Bringing Born-Digital Speed to Every Life Sciences Workflow appeared first on the Emerson Automation Experts blog.